← Leaderboards
Juan Bustillo
University Of New Mexico
$587,257
Attributed
$587,257
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$587,257 · 1
By mechanism
M01$587,257 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico
Same institution · by research overlap
- David S Schade$14,177,133
- William R. Miller$9,331,399
- Holly Barrett Waldron$22,751,877
- Natasha Slesnick$24,381,625
- Kimberly K Leslie$10,616,588
Others in their field
Top investigators on “Antipsychotic Agents”
- P Jeffrey Conn · Vanderbilt University$24,634,463
- Abraham Aizer Brody · New York University School Of Medicine$22,358,187
- Constantine G Lyketsos · Johns Hopkins University$14,554,427
- John H Krystal · Yale University$14,263,729
- Dilip V Jeste · University Of California San Diego$13,885,388
- Thomas Scott Stroup · University Of North Carolina Chapel Hill$12,935,020
Research focus
Antipsychotic AgentsBody WeightClinical ResearchClinical TrialsDrug Adverse EffectFluoxetineHuman SubjectHuman Therapy EvaluationNutrition Disorder ChemotherapyOutcomes ResearchWeight Control AgentWeight Loss
Grant awards (4)
TREATMENT OF WEIGHT GAIN W/ FLUOXETINE IN OLANZAPINE TREATED PATIENTS$282,412
M01 · FY2002 · RR
TREATMENT OF WEIGHT GAIN W/ FLUOXETINE IN OLANZAPINE TREATED PATIENTS$282,412
M01 · FY2001 · RR
TREATMENT OF WEIGHT GAIN W/ FLUOXETINE IN OLANZAPINE TREATED PATIENTS$22,433
M01 · FY2000 · RR
TREATMENT OF WEIGHT GAIN W/ FLUOXETINE IN OLANZAPINE TREATED PATIENTS$0
M01 · FY2000 · RR